Summary of Use during Lactation

Lonapegsomatropin is a long-acting prodrug of somatropin, which has been used safely in nursing mothers. The PEG component it is not likely to be enter breastmilk or reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Lonapegsomatropin is not contraindicated in nursing mothers.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date. However, somatropin has been reported to increase milk production.

Alternate Drugs to Consider

Somatropin

Substance Name

Lonapegsomatropin

CAS Registry Number

1934255-39-6

Drug Class

Breast Feeding

Lactation

Human Growth Hormone